How DNA’s chemical marks become an age estimate
An epigenetic clock looks not at changes to the DNA sequence, but at chemical tags—often methyl groups—attached at particular points along it. These tags help regulate how genes are used. Their patterns tend to shift with age, so a clock can measure selected sites and combine them into a statistical estimate.
The estimate comes from patterns learned across many people: a clock is calibrated to predict something such as chronological age or, in some designs, an age-related health outcome. It is therefore a model’s reading of biological signals, not a direct inspection of every cell or organ.
Why one clock cannot describe the whole body
Different tissues can carry different patterns, and a blood sample cannot automatically stand in for the brain, heart, or other organs. Results can also depend on which sites a particular clock measures and what it was built to predict. Two clocks may give different estimates for the same person without either serving as a complete verdict on that person’s health.
That distinction matters when interpreting a result: an estimate above or below a person’s calendar age is a clue about a measured pattern, not a diagnosis or a precise forecast of lifespan. Biological aging is broader than any single number, involving many tissues and processes that one test cannot fully capture.
What a changed reading can—and cannot—show
If a clock’s estimate changes between tests, it may indicate that the measured pattern changed. But that alone does not prove that the body has become younger or that a treatment has improved health; the result must be interpreted in light of the clock’s design, the sample, and other evidence. The practical value is as a research tool for tracking aging-related signals—not as a replacement for a clinical picture of how someone is doing.
